GLUE
Price
$18.39
Change
+$0.63 (+3.55%)
Updated
Jun 17, 04:59 PM (EDT)
Capitalization
1.5B
50 days until earnings call
Intraday BUY SELL Signals
PEGA
Price
$30.23
Change
-$2.12 (-6.55%)
Updated
Jun 17, 04:59 PM (EDT)
Capitalization
5.41B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs PEGA

Header iconGLUE vs PEGA Comparison
Open Charts GLUE vs PEGABanner chart's image
GLUE vs PEGA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLUE vs. PEGA commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and PEGA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 18, 2026
Stock price -- (GLUE: $17.75 vs. PEGA: $32.36)
Brand notoriety: GLUE and PEGA are both not notable
GLUE represents the Biotechnology, while PEGA is part of the Packaged Software industry
Current volume relative to the 65-day Moving Average: GLUE: 91% vs. PEGA: 106%
Market capitalization -- GLUE: $1.5B vs. PEGA: $5.41B
GLUE [@Biotechnology] is valued at $1.5B. PEGA’s [@Packaged Software] market capitalization is $5.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $115.02B to $0. The market cap for tickers in the [@Packaged Software] industry ranges from $195.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Packaged Software] industry is $8.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whilePEGA’s FA Score has 2 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • PEGA’s FA Score: 2 green, 3 red.
According to our system of comparison, both GLUE and PEGA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 6 TA indicator(s) are bullish while PEGA’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 6 bullish, 4 bearish.
  • PEGA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than PEGA.

Price Growth

GLUE (@Biotechnology) experienced а +6.86% price change this week, while PEGA (@Packaged Software) price change was -5.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.31%, and the average quarterly price growth was +2179.40%.

The average weekly price growth across all stocks in the @Packaged Software industry was +1.94%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was +3.27%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 06, 2026.

PEGA is expected to report earnings on Jul 29, 2026.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Packaged Software (+1.94% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEGA($5.41B) has a higher market cap than GLUE($1.5B). GLUE has higher P/E ratio than PEGA: GLUE (49.25) vs PEGA (17.49). GLUE YTD gains are higher at: 13.202 vs. PEGA (-45.748). PEGA has higher annual earnings (EBITDA): 221M vs. GLUE (-139.94M). GLUE has more cash in the bank: 666M vs. PEGA (474M). GLUE has less debt than PEGA: GLUE (39.1M) vs PEGA (72.1M). PEGA has higher revenues than GLUE: PEGA (1.7B) vs GLUE (43M).
GLUEPEGAGLUE / PEGA
Capitalization1.5B5.41B28%
EBITDA-139.94M221M-63%
Gain YTD13.202-45.748-29%
P/E Ratio49.2517.49282%
Revenue43M1.7B3%
Total Cash666M474M141%
Total Debt39.1M72.1M54%
FUNDAMENTALS RATINGS
PEGA: Fundamental Ratings
PEGA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEPEGA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 17 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
PEGA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KXI68.380.07
+0.10%
iShares Global Consumer Staples ETF
TEND27.20-0.03
-0.10%
iShares Large Cap 10% Trgt Buffr Dec ETF
PTIN37.01-0.07
-0.18%
Pacer Trendpilot International ETF
LLYX24.51-0.31
-1.25%
Defiance Daily Target 2X Long LLY ETF
BRF16.80-0.37
-2.18%
VanEck Brazil Small-Cap ETF

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-2.04%
CRNX - GLUE
42%
Loosely correlated
-0.34%
IMNM - GLUE
38%
Loosely correlated
-0.89%
AXON - GLUE
38%
Loosely correlated
-1.76%
RVMD - GLUE
37%
Loosely correlated
-2.17%
KURA - GLUE
37%
Loosely correlated
-1.42%
More

PEGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEGA has been loosely correlated with HUBS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PEGA jumps, then HUBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEGA
1D Price
Change %
PEGA100%
-1.10%
HUBS - PEGA
59%
Loosely correlated
-1.73%
TTAN - PEGA
57%
Loosely correlated
-3.24%
CRM - PEGA
57%
Loosely correlated
-1.73%
FRSH - PEGA
56%
Loosely correlated
-0.10%
PCOR - PEGA
56%
Loosely correlated
-1.39%
More